SKYE

Skye Bioscience, Inc.

Pharmaceutical PreparationsNasdaqNon-accelerated filer<br>Smaller reporting company

Total Trades

9

Buys

2

Sells

6

Largest Trade

N/A

Insiders

6

Institutional Funds

34

Inst. Value

$1M+

Activist Filings

11

Insider Trades

InsiderTitleTypeValueSharesPriceDate
Schwab Andrew J.DirectorSELL$500K+231K$3.46Aug 22, 2025
5AM Partners VII, LLC10% OwnerSELL$500K+231K$3.46Aug 22, 2025
Diep Tuan TuChief Development …SELL$50K–$100K20K$4.99Nov 20, 2024
ARSENAULT KAITLYNCFOSELL$100K–$500K43K$4.99Nov 20, 2024
DHILLON PUNITCEOSELL$100K–$500K83K$4.99Nov 20, 2024
Grayson Paul A.DirectorSELL$100K–$500K87K$4.99Nov 20, 2024
5AM Partners VII, LLC10% OwnerBUY$1M+5.2M$2.31Feb 2, 2024
DHILLON PUNITCEOGRANTN/A20.3MAug 29, 2023
DHILLON PUNITCEOBUY$15K–$50K881K$0.02Aug 29, 2023
🔓Seeing ranges? Sign in for exact trade values — free forever

Institutional Ownership

13F filings as of Dec 31, 2025 · 34 funds holding

Activist & 5%+ Owners

SC 13D/13G filings — investors holding 5%+ of outstanding shares

5AM Partners VII, LLC

SC 13D/A · Dec 16, 2025

29.2%

9.9M shares

Schonfeld Strategic Advisors LLC

SC 13G/A · Aug 14, 2025

3.6%

1.1M shares

Schonfeld Strategic Advisors LLC

SC 13G · May 15, 2025

5.2%

1.6M shares

Sphera Funds Management Ltd.

SC 13G/A · Apr 10, 2025

4.8%

1.5M shares

5AM Partners VII, LLC

SC 13D/A · Dec 19, 2024

30.8%

9.9M shares

0.0%

0 shares

4.3%

1.3M shares

5.7%

1.7M shares

5AM Ventures VII, L.P.

SC 13D/A · Mar 13, 2024

33.9%

10.1M shares

5.4%

1.3M shares

5AM Ventures VII, L.P.

SC 13D/A · Jan 31, 2024

37.3%

9.6M shares

View on Google Finance →